Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Inhibrx Biosciences Inc
(NQ:
INBX
)
13.34
+0.35 (+2.69%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Inhibrx Biosciences Inc
< Previous
1
2
3
Next >
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
August 15, 2022
Via
Benzinga
Inhibrx Secures European Commission Orphan Medicinal Product Designation For Bone Cancer Candidate
August 15, 2022
The European Commission (EC) has granted orphan medicinal product designation to Inhibrx’s (NASDAQ: INBX) lead asset INBRX-109 for the treatment of chondrosarcoma. The regulatory grant was based on a...
Via
Benzinga
Alphabet, Dyne Therapeutics And 74 Biggest Movers From Yesterday
July 06, 2022
Gainers Enjoy Technology, Inc. (NASDAQ: ENJY) shares jumped 81.5% to close at $0.31 on Tuesday.
Via
Benzinga
Inhibrx's INBRX-101 Shows Favorable Safety Profile In An Inherited Disorder
May 16, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
June 02, 2022
During the Thursday's session, 100 stocks hit new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
May 17, 2022
Via
Benzinga
73 Biggest Movers From Yesterday
May 17, 2022
Gainers AgriFORCE Growing Systems Ltd. (NASDAQ: AGRI) shares jumped 65.9% to close at $2.77 on Monday after gaining around 10% on Friday.
Via
Benzinga
The Week Ahead In Biotech: Gene & Cell Therapy Conference, Tapering Earnings News, OKYO Pharma IPO And More
May 16, 2022
Biopharma stocks remained largely unchanged in the week ending May 13, with the defensive nature of the sector coming to its aid. Stocks reacted to the broader market move and earnings news from...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 16, 2022
March 16, 2022
Upgrades Bernstein upgraded the previous rating for Stryker Corp (NYSE:SYK) from Market Perform to Outperform. For the fourth quarter, Stryker had an EPS of $2.71, compared to...
Via
Benzinga
28 Stocks Moving In Tuesday's Mid-Day Session
January 25, 2022
Gainers Sierra Oncology, Inc. (NASDAQ: SRRA) shares jumped 47.8% to $22.93 after the company unveiled topline data for momelotinib in myelofibrosis patients who are symptomatic,...
Via
Benzinga
Inhibrx Shares Interim Data On INBRX-106 - Keytruda Combo Therapy In Solid Tumors
January 05, 2022
Inhibrx Inc (NASDAQ: INBX) announced initial results from Part 3 (combination dose escalation) of the Phase 1 trial of INBRX-106 combined with Keytruda for solid...
Via
Benzinga
Inhibrx Precision Cancer Antibody Receives FDA Orphan Drug Tag For Rare Bone Cancer
December 02, 2021
The FDA has granted Orphan Drug designation to Inhibrx Inc's (NASDAQ: INBX) INBRX-109 for chondrosarcoma. Chondrosarcoma is an orphan bone cancer with...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
November 10, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus MorphoSys COO To Leave To Pursue Other Opportunities MorphoSys AG (NASDAQ:...
Via
Benzinga
Exposures
COVID-19
45 Biggest Movers From Yesterday
October 13, 2021
Gainers ESSTech Inc (NYSE: GWH) shares surged 128.4% to close at $23.80 onTuesday. ESS Inc, the Bill Gates-backed battery maker went public on the NewYork Stock Exchange on...
Via
Benzinga
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 12, 2021
Gainers NRX Pharmaceuticals (NASDAQ:NRXP...
Via
Benzinga
30 Stocks Moving In Tuesday's Mid-Day Session
October 12, 2021
Gainers ESS Tech Inc (NYSE: GWH) shares jumped 96.4% to $20.46. ESS Inc, the Bill Gates-backed battery maker went public on the New York Stock Exchange on Monday after...
Via
Benzinga
Here's Why Inhibrx Stock Is on the Move Today
October 12, 2021
The first clinical trial results for a candidate for the treatment of alpha-1 antitrypsin deficiency look highly encouraging.
Via
The Motley Fool
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 12, 2021
Gainers Viridian Therapeutics (NASDAQ:VRDN) stock rose 22.49% to $19.17 during Tuesday's pre-market session. The company's market cap stands at $331.8 million. Inhibrx (...
Via
Benzinga
Inhibrx Launches Mid-Stage Bone Cancer Study With INBRX-109, Amends Loan Agreement With Oxford
June 22, 2021
Inhibrx Inc (NASDAQ: INBX) has initiated a potential registration-enabling Phase 2 study of INBRX-109 in conventional chondrosarcoma, a type of bone cancer that...
Via
Benzinga
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
October 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 11) AstraZeneca Plc (NASDAQ:...
Via
Benzinga
Exposures
COVID-19
Benzinga's Top Ratings Upgrades, Downgrades For September 21, 2021
September 21, 2021
Upgrades According to Compass Point, the prior rating for TriplePoint Venture Growth BDC Corp (NYSE:
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
June 10, 2021
Gainers Tyme Technologies (NASDAQ:TYME) s...
Via
Benzinga
35 Stocks Moving In Monday's Mid-Day Session
May 24, 2021
Gainers Scopus BioPharma Inc. (NASDAQ: SCPS) shares jumped 123.7% to $13.33 after the company reported the FDA approval of IND application for CpG-STAT3siRNA, its distinctive...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal
June 22, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 21) Agios Pharmaceuticals, Inc...
Via
Benzinga
66 Biggest Movers From Yesterday
June 03, 2021
Gainers AMC Entertainment Holdings, Inc. (NYSE: AMC) surged 95.2% to close at $62.55 on Wednesday amid renewed interest from retail investors. AMC Entertainment shares jumped...
Via
Benzinga
52 Biggest Movers From Yesterday
May 25, 2021
Gainers Scopus BioPharma Inc. (NASDAQ: SCPS) shares climbed 72% to close at $10.25 on Monday after the company reported the FDA approval of IND application for CpG-STAT3siRNA,...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron
May 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ...
Via
Benzinga
Exposures
COVID-19
Stocks That Hit 52-Week Lows On Tuesday
May 11, 2021
Before 10 a.m. ET Tuesday, 173 stocks hit new 52-week lows. Intriguing Points: The largest company by market cap to set a new 52-week low was Snowflake (NYSE:SNOW...
Via
Benzinga
The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs
May 07, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:...
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.